Opendata, web and dolomites

REBOOT SIGNED

First-in-class implants for bone regeneration surgery after a bone, ligament or tendon injury

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 REBOOT project word cloud

Explore the words cloud of the REBOOT project. It provides you a very rough idea of what is the project "REBOOT" about.

surgery    knee    turnover    patented    pain    international    20    outcomes    structure    msd    capablity    too    msds    revision    injuries    made    re    full    recreate    disruptive    synthetic    enter    biocomposite    functional    healing    quality    perspectives    manufacturing    cruciate    feasibility    industrial    2015    operation    materials    launch    inflammation    sales    2018       million    regeneration    orthopaedic    imperfect    mixed    musculoskeletal    trauma    disorders    bone    validated    abnormal    world    rate    millions    glass    marketed    surgical    formula    bioabsorbable    transition    toward    days    noraker    market    class    reboot    community    develops    action    life    experiencing    revolutionary    bioresorbable    native    patients    people    follow    injury    15    screw    bones    billions    ages    30    instrument    suffering    ligaments    ligament    weights    tendon    multiplied    fragile    first    shows    bioactive    regenerative    adoption    ceramic    population    break    poor    metallic    chronic    100    leaving    polymer    implants    sme    spiral    create    worldwide   

Project "REBOOT" data sheet

The following table provides information about the project.

Coordinator
NORAKER 

Organization address
address: 11/13 AVENUE ALBERT EINSTEIN CENTRE SCIENTIFIQUE ET TECHNOLOGIQUE
city: VILLEURBANNE
postcode: 69100
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Total cost 3˙545˙000 €
 EC max contribution 2˙481˙500 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-2
 Funding Scheme SME-2
 Starting year 2019
 Duration (year-month-day) from 2019-11-01   to  2021-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    NORAKER FR (VILLEURBANNE) coordinator 2˙481˙500.00

Map

 Project objective

NORAKER develops first-in-class implants for regenerative orthopaedic surgery to offer full healing to patients suffering from a bone, ligament or tendon injury. With project REBOOT, NORAKER will create the market of bone regeneration surgery. Each year in Europe, 1,6 million people require orthopaedic surgery after a bone, ligament or tendon injury, with many more cases expected as population ages. The current implants (made of metallic or bioresorbable materials) show imperfect healing outcomes, leaving millions of patients with fragile bones and poor quality of life (with 30% of inflammation, 20% of revision surgery and millions suffering from chronic pain and musculoskeletal disorders, MSDs). It weights billions of follow-up costs on the community. Enter NORAKER’s biocomposite surgical implants, made of bioactive glass – a revolutionary ceramic – mixed with a synthetic polymer, both bioabsorbable. This technology shows disruptive regeneration action: it can recreate up to 100% of the native-like functional bone structure with no inflammation, no abnormal pain, no MSD and a very low re-operation rate (4%). Today this patented technology is adapted to knee cruciate ligaments regeneration (with a world-first biocomposite screw marketed in 2015). In a SME Instrument Phase 1 project (2018), NORAKER has validated the feasibility of a new biocomposite formula with broader perspectives of regeneration for tendon, ligament and bone injuries. The Phase 2 project will do the industrial scale-up of this biocomposite and launch the industrial production of the first range of implants for the bone trauma market. Their adoption will support the transition toward regenerative orthopaedic surgery and break the spiral of pain and MSDs, which too many patients are experiencing these days. With this disruptive offer, NORAKER will become a scale-up operating worldwide, with a large manufacturing capablity, international sales and turnover multiplied by 15 in five years.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "REBOOT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "REBOOT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Colourganisms (2020)

Microbial production of custom-made, pure and sustainable anthocyanins

Read More  

TAPPXSSAI (2019)

Development of a system for automatic ad insertion into on-demand streaming video to provide new monetization mechanisms to the media industry

Read More  

BeatsDigTherapeutics (2019)

Project SCALE: Tailored Digital Therapeutics for Neurological and Brain Disorders

Read More